Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Research on Efficacy and Safety of Arsenic Trioxide Combined With Chemotherapy in p53-mutated Pediatric Cancer Patients:A Prospective,Single-arm, Multi-center Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06088030
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:23.294751+00:00
Published At
2024-01-03T00:00:00+00:00
Record Updated At
2024-01-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pediatric Cancer", "Li-Fraumeni Syndrome", "p53 Mutations"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-01-03"
protocolSection.identificationModule.nctId
"NCT06088030"
protocolSection.identificationModule.officialTitle
"Clinical Research on Efficacy and Safety of Arsenic Trioxide Combined With Chemotherapy in p53-mutated Pediatric Cancer Patients\uff1aA Prospective\uff0cSingle-arm, Multi-center Study"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Pediatric Cancer (protocolSection.conditionsModule.conditions)
  • Li-Fraumeni Syndrome (protocolSection.conditionsModule.conditions)
  • p53 Mutations (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.